⌘K

Login Start Free

Home/Filings/4/0000905718-18-001001

4//SEC Filing

Williams Rodney James 4

Accession 0000905718-18-001001

CIK 0001684144other

View on SEC.gov Company Profile

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 7:01 PM ET

Size

7.6 KB

Accession

0000905718-18-001001

Insider Transaction Report

Form 4

Period: 2018-12-20

Zomedica Pharmaceuticals Corp.ZOM

Williams Rodney James

Director

Transactions

Exercise/Conversion
Common Shares, without par value
2018-12-20$1.20/sh+26,900$32,280→ 161,900 total
Exercise/Conversion
Stock Option (right to buy)
2018-12-20−26,900→ 0 total
Exercise: $1.20From: 2016-12-21Exp: 2018-12-21→ Common Shares, without par value (200,000 underlying)

Holdings

Common Shares, without par value
(indirect: By Trust)
40,000

Footnotes (1)

[F1]The options vested upon grant.

Documents

1 file

4
zomedica_form4dec202018.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Zomedica Pharmaceuticals Corp.

CIK 0001684144

Entity typeother

Related Parties

1

filerCIK 0001722780

Filing Metadata

Form type: 4
Filed: Dec 26, 7:00 PM ET
Accepted: Dec 27, 7:01 PM ET
Size: 7.6 KB

View on SEC.gov